Overview
- 91 inspections across 78 sites are on record.
- 505 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-18.
At a glance
Inspections
91
Sites
78
Observations
505
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| LGM Pharma Solutions, LLC | 18 May 2026 | Human Drugs | View 483 → |
| Samson Pharmaceuticals, Inc | 29 Apr 2026 | Human Drugs | View 483 → |
| WE Soda Wyoming | 26 Mar 2026 | Human Drugs | On file |
| K.C. Pharmaceuticals, Inc | 13 Feb 2026 | Human Drugs | View 483 → |
| B. Braun US Pharmaceutical Manufacturing, LLC | 21 Nov 2025 | Human Drugs | View 483 → |
Sites inspected
LGM Pharma Solutions, LLCIrvine, United States1 insp.
Samson Pharmaceuticals, IncCommerce, United States1 insp.
WE Soda WyomingGreen River, United States1 insp.
K.C. Pharmaceuticals, IncPomona, United States1 insp.
B. Braun US Pharmaceutical Manufacturing, LLCIrvine, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Daniel J Roberts7 shared
Jay-Ar C Bendo6 shared
Amanda L Fyles6 shared
Cecilia H Kieu5 shared
Uttaniti Limchumroon5 shared
Amir Alavi5 shared
Joey V Quitania4 shared
Linda Thai4 shared
Christopher R Czajka4 shared
Minh D Phan4 shared
Full investigator report
Get the verbatim findings behind Walden H Lee's 505 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site